Press Releases Verona Pharma plc

Equities

VRNA

US9250501064

Market Closed - Nasdaq Other stock markets 01:30:00 30/04/2024 am IST			5-day change	1st Jan Change
15.56 ^USD	+0.58%		-1.02%	-21.73%

22/04	European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading	MT
16/04	European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Verona Pharma : AGM 2024 Results	26/04	PU
Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update	25/04	AQ
Verona Pharma : Notice and Proxy Statement AGM 2024	21/03	PU
Verona Pharma : Form of Proxy Card (Ordinary Shareholders)	21/03	PU
Verona Pharma : Notice and Proxy Statement AGM 2024	20/03	PU
Verona Pharma : Form of Proxy Card (Ordinary Shareholders)	20/03	PU
Andrew Fisher Joins Verona Pharma as General Counsel	04/03	AQ
Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	29/02	AQ
Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update	15/02	AQ
Michael Austwick Joins Verona Pharma as Non-Executive Director	01/02	AQ
Verona Pharma to Present at 42nd Annual J.P. Morgan Healthcare Conference	03/01	AQ
Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital	02/01	AQ
Verona Pharma : Change in Certifying Accountants - Form 8-K	19/12	PU
Verona Pharma’s President and CEO David Zaccardelli Wins Executive of the Year SCRIP Award	17/11	AQ
Verona Pharma Announces November 2023 Investor Conference Participation	08/11	AQ
Verona Pharma : VRNA Investor Presentation November 2023	07/11	PU
Verona Pharma : VRNA Presentation November 2023	02/11	PU
Verona Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update	02/11	AQ
Verona Pharma to Report Third Quarter 2023 Financial Results and Provide Corporate Update	19/23/19	AQ
Verona Pharma to Host Investor Update on Commercialization Preparation for Ensifentrine on October 18, 2023	06/23/06	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Verona Pharma plc

Equities

VRNA

US9250501064

Press Releases

Filters